These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 28486226

  • 1. Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma.
    Bağırsakçı E, Şahin E, Atabey N, Erdal E, Guerra V, Carr BI.
    Oncology; 2017; 93(2):136-142. PubMed ID: 28486226
    [Abstract] [Full Text] [Related]

  • 2. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
    Carr BI, Guerra V.
    Int J Biol Markers; 2017 Oct 31; 32(4):e391-e396. PubMed ID: 28862714
    [Abstract] [Full Text] [Related]

  • 3. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S, Tsuji T.
    Hepatology; 1998 Feb 31; 27(2):599-607. PubMed ID: 9462663
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
    Akkiz H, Carr BI, Yalçın K K, Guerra V, Kuran S, Altıntaş E, Üsküdar O, Karaoğullarından Ü, Özakyol A, Tokmak S, Yücesoy M, Bahçeci Hİ, Ülkü A, Akçam T, Yalçın Polat K, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Ballı T, Demir A, Arslan B, Doran F.
    Oncology; 2018 Feb 31; 94(2):116-124. PubMed ID: 29207378
    [Abstract] [Full Text] [Related]

  • 5. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.
    Carr BI, Guerra V, Donghia R, Yilmaz S.
    J Gastrointest Cancer; 2021 Dec 31; 52(4):1340-1349. PubMed ID: 34611834
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
    Fujioka M, Nakashima Y, Nakashima O, Kojiro M.
    Hepatology; 2001 Dec 31; 34(6):1128-34. PubMed ID: 11732002
    [Abstract] [Full Text] [Related]

  • 8. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
    Carr BI, Guerra V.
    Dig Dis Sci; 2016 Mar 31; 61(3):937-47. PubMed ID: 26576554
    [Abstract] [Full Text] [Related]

  • 9. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY, Chen L, Chen HY, Hu L, Li L, Sun HY, Jiang F, Zhao J, Liu GM, Tang J, Chen CY, Yang YC, Chang YX, Liu H, Zhang J, Yang Y, Huang G, Shen F, Wu MC, Zhou WP, Wang HY.
    Gastroenterology; 2013 Dec 31; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [Abstract] [Full Text] [Related]

  • 10. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
    Giannini EG, Sammito G, Farinati F, Ciccarese F, Pecorelli A, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Trevisani F, Italian Liver Cancer (ITA.LI.CA) Group.
    Cancer; 2014 Jul 15; 120(14):2150-7. PubMed ID: 24723129
    [Abstract] [Full Text] [Related]

  • 11. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y, Tsuneyoshi M.
    J Surg Oncol; 2009 Dec 01; 100(7):575-9. PubMed ID: 19697358
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.
    Kitai S, Kudo M, Izumi N, Kaneko S, Ku Y, Kokudo N, Sakamoto M, Takayama T, Nakashima O, Kadoya M, Matsuyama Y, Matsunaga T.
    Dig Dis; 2014 Dec 01; 32(6):717-24. PubMed ID: 25376289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG, Marenco S, Borgonovo G, Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F, Italian Liver Cancer (ITA.LI.CA) group.
    Hepatology; 2012 Oct 01; 56(4):1371-9. PubMed ID: 22535689
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.
    Ann Surg Oncol; 2012 Oct 01; 19(11):3556-65. PubMed ID: 22588469
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, Changchien CS, Lee CM, Tai MH.
    Cancer; 2003 Apr 15; 97(8):1929-40. PubMed ID: 12673720
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS, Ou YH, Hsu HC.
    Eur J Cancer; 2007 Mar 15; 43(4):736-44. PubMed ID: 17267202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.